بدائل البحث:
significantly causes » significantly changes (توسيع البحث), significant cause (توسيع البحث), significantly used (توسيع البحث)
causes increased » cases increased (توسيع البحث), use increased (توسيع البحث), values increased (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
significantly causes » significantly changes (توسيع البحث), significant cause (توسيع البحث), significantly used (توسيع البحث)
causes increased » cases increased (توسيع البحث), use increased (توسيع البحث), values increased (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
-
1
-
2
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
3
-
4
-
5
Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice.
منشور في 2024"…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …"
-
6
Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth.
منشور في 2025الموضوعات: -
7
-
8
Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width.
منشور في 2021"…Shaded regions correspond to the standard error of the mean and dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs. …"
-
9
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …"
-
10
-
11
-
12
-
13
ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection.
منشور في 2025الموضوعات: -
14
-
15
-
16
-
17
Stability during repeated VR video sessions and during the control tests of quiet stance.
منشور في 2024الموضوعات: -
18
Standardization of the posturography assessment and virtual reality procedure.
منشور في 2024الموضوعات: -
19
-
20